loading

Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
21.51%
4.044
3.328 3.633 3.103 3.643
Operating Income/Loss
22.23%
-7.61
-6.226 -6.48 -5.213 -6.024
Income/Loss From Continuing Operations Before Tax
21.68%
-7.549
-6.204 -6.408 -5.101 -5.883
Income/Loss From Continuing Operations After Tax
21.68%
-7.549
-6.204 -6.408 -5.101 -5.883
Net Income/Loss
21.68%
-7.549
-6.204 -6.408 -5.101 -5.883
Preferred Stock Dividends And Other Adjustments
1.479
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
448.54%
4.049
0.7381 1.4585 10.55 3.5199
Diluted Average Shares
448.54%
4.049
0.7381 1.4585 10.55 3.5199
Basic Earnings Per Share
73.45%
-2.23
-8.40 -4.39 -0.48 -1.67
Diluted Earnings Per Share
73.45%
-2.23
-8.40 -4.39 -0.48 -1.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
1.479
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):